An immunoradiometric assay for factor III (tissue thromboplastin)

Area of Science:

• Biochemistry
• Immunology
• Hematology

Background:

• Tissue thromboplastin (factor III) plays a critical role in the coagulation cascade.
• Accurate detection of circulating tissue thromboplastin is essential for understanding hemostasis and thrombosis.
• Existing methods for factor III detection may have limitations in sensitivity or specificity.

Purpose of the Study:

• To develop and validate a novel solid-phase immunoradiometric assay for quantifying tissue thromboplastin (factor III).
• To assess the utility of this assay in detecting circulating factor III in relevant biological models and clinical settings.

Main Methods:

• Establishment of a solid-phase immunoradiometric assay utilizing 125I-labelled factor III antibodies.
• Coating of polyvinyl tubes with purified factor III apoprotein to serve as the solid phase.
• Measurement of tissue thromboplastin by its competitive displacement of antibody binding.

Main Results:

• The assay successfully detected tissue thromboplastin based on its inhibitory effect on antibody binding.
• Circulating tissue thromboplastin was identified in experimental animals administered crude or purified factor III.
• The assay demonstrated potential for detecting factor III in patients undergoing major orthopaedic surgery.

Conclusions:

• A sensitive and specific solid-phase immunoradiometric assay for tissue thromboplastin (factor III) has been successfully developed.
• This assay is capable of detecting circulating factor III in both experimental and clinical contexts.
• The established method offers a valuable tool for research and clinical monitoring of coagulation-related conditions.